Filing Details
- Accession Number:
- 0001493152-18-014616
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-18 09:10:07
- Reporting Period:
- 2018-10-15
- Accepted Time:
- 2018-10-18 09:10:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1360214 | Imprimis Pharmaceuticals Inc. | IMMY | Pharmaceutical Preparations (2834) | 450567010 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1542484 | J Robert Kammer | C/O Imprimis Pharmaceuticals, Inc. 12264 El Camino Real, Suite 350 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-10-15 | 10,000 | $3.00 | 909,827 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan, as amended, adopted by the Reporting Person.
Billionaire Hedge Funds
